PANOVA-3: Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields, 150kHz)concomitant with gemcitabine and nab-paclitaxel for front-line treatment of locally-advanced pancreaticadenocarcinoma

Project: Research project

Project Details

Description

PANOVA-3: Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields, 150kHz) concomitant with gemcitabine and nab-paclitaxel for front-line treatment of locally-advanced pancreatic adenocarcinoma
StatusActive
Effective start/end date5/1/185/31/22

Funding

  • NOVOCURE INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.